| Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. G Renier, E Skamene, J DeSanctis, D Radzioch Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 13 (10), 1515 …, 1993 | 238 | 1993 |
| Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection J Corado, F Toro, H Rivera, NE Bianco, L Deibis, JB De Sanctis Clinical & Experimental Immunology 109 (3), 451-457, 1997 | 201 | 1997 |
| Peripheral muscle alterations in non-COPD smokers MM de Oca, E Loeb, SH Torres, J De Sanctis, N Hernández, C Tálamo Chest 133 (1), 13-18, 2008 | 190 | 2008 |
| Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients SH Torres, JB De Sanctis, LM De Briceno, N Hernandez, HJ Finol Journal of endocrinology 181 (3), 419-427, 2004 | 189 | 2004 |
| Skeletal muscle inflammation and nitric oxide in patients with COPD MM De Oca, SH Torres, J De Sanctis, A Mata, N Hernandez, C Talamo European Respiratory Journal 26 (3), 390-397, 2005 | 182 | 2005 |
| Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene W Wojciechowski, J DeSanctis, E Skamene, D Radzioch The Journal of Immunology 163 (5), 2688-2696, 1999 | 167 | 1999 |
| Fenretinide corrects newly found ceramide deficiency in cystic fibrosis C Guilbault, JB De Sanctis, G Wojewodka, Z Saeed, C Lachance, ... American journal of respiratory cell and molecular biology 38 (1), 47-56, 2008 | 128 | 2008 |
| Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide C Guilbault, G Wojewodka, Z Saeed, M Hajduch, E Matouk, JB De Sanctis, ... American journal of respiratory cell and molecular biology 41 (1), 100-106, 2009 | 113 | 2009 |
| Serum adipokine levels in patients with systemic lupus erythematosus: Brief Definite Report JB De Sanctis, M Zabaleta, NE Bianco, JV Garmendia, L Rivas Autoimmunity 42 (4), 272-274, 2009 | 112 | 2009 |
| Effects of Flavonoids and Its Derivatives on Immune Cell Responses JBDS Gricelis Martínez, Michael R. Mijares Recent Patents on Inflammation & Allergy Drug Discovery 13 (2), 2019 | 88 | 2019 |
| Increased lipid peroxidation and abnormal fatty acid profiles in seminal and blood plasma of normozoospermic males from infertile couples I Oborna, G Wojewodka, JB De Sanctis, H Fingerova, M Svobodova, ... Human reproduction 25 (2), 308-316, 2010 | 77 | 2010 |
| Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice R López-Vales, A Redensek, TAA Skinner, KI Rathore, N Ghasemlou, ... Journal of Neuroscience 30 (9), 3220-3226, 2010 | 76 | 2010 |
| An overview of adjuvant formulations and delivery systems A García, JB De Sanctis Apmis 122 (4), 257-267, 2014 | 74 | 2014 |
| Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase. G Renier, E Skamene, JB DeSanctis, D Radzioch Journal of lipid research 35 (2), 271-278, 1994 | 64 | 1994 |
| The marine sponge toxin agelasine B increases the intracellular Ca2+ concentration and induces apoptosis in human breast cancer cells (MCF-7) AA Pimentel, P Felibertt, F Sojo, L Colman, A Mayora, ML Silva, H Rojas, ... Cancer chemotherapy and pharmacology 69, 71-83, 2012 | 60 | 2012 |
| Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients G Wojewodka, JB De Sanctis, J Bernier, J Bérubé, HG Ahlgren, J Gruber, ... PloS one 9 (2), e88567, 2014 | 59 | 2014 |
| Cellular senescence: molecular targets, biomarkers, and senolytic drugs N Kudlova, JB De Sanctis, M Hajduch International Journal of Molecular Sciences 23 (8), 4168, 2022 | 52 | 2022 |
| Pharmacological properties of thalidomide and its analogues J B De Sanctis, M Mijares, A Suárez, R Compagnone, J Garmendia, ... Recent patents on inflammation & allergy drug discovery 4 (2), 144-148, 2010 | 51 | 2010 |
| Secretion of cytokines by natural killer cells primed with interleukin‐2 and stimulated with different lipoproteins JB De Sanctis, I Blanca, NE Bianco Immunology 90 (4), 526-533, 1997 | 50 | 1997 |
| Fenretinide prevents the development of osteoporosis in Cftr-KO mice Z Saeed, C Guilbault, JB De Sanctis, J Henri, D Marion, R St-Arnaud, ... Journal of Cystic Fibrosis 7 (3), 222-230, 2008 | 45 | 2008 |
Marian HajduchInstitute of Molecular and Translational Medicine, Palacky UniversityVerified email at upol.cz
